Tetrasodium pyrophosphate
Common Name: |
Tetrasodium pyrophosphate |
IUPAC Name: |
tetrasodium;phosphonato phosphate |
Molecular Formula: |
H4O7P2 |
SMILES: |
[O-]P(=O)([O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+] |
Inchi: |
1S/4Na.H4O7P2/c;;;;1-8(2,3)7-9(4,5)6/h;;;;(H2,1,2,3)(H2,4,5,6)/q4*+1;/p-4 |
Inchi Key: |
FQENQNTWSFEDLI-UHFFFAOYSA-J |
Cas No: |
7722-88-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
265.90 |
Mass (g/mol) |
265.871 |
Molar Refractivity |
19.04 |
Net Charge |
-3 |
HBD |
5 |
HBA |
6 |
Rt Bonds |
2 |
Rings |
|
TPSA |
155.23 |
Hetero Atoms |
9 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
988.00 |
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
-0.812 |
iLOGP |
0.52 |
XLOGP3 |
-2.84 |
WLOGP |
-3.22 |
MLOGP |
-2.75 |
ESOL Log S |
0.90 |
ESOL Solubility (mg/ml) |
1430 |
ESOL Solubility (mol/l) |
7.91 |
ESOL Class: esol_class |
Highly soluble |
Ali Log S |
1.08 |
Ali Solubility (mg/ml) |
2160 |
Ali Solubility (mol/l) |
12 |
Ali Class |
Highly soluble |
Silicos-IT LogSw |
2.17 |
Silicos-IT Solubility (mg/ml) |
26300 |
Silicos-IT Solubility (mol/l) |
146 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
Low |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-9.42 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.414 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
4.823 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |